Dilbert Creator Dies at 68 After Cancer and Let me share Prostate Cancer Drug Sales.

Rest in peace...

The cartoonist who made millions laugh at the absurdities of office life, the pointless meetings, the evil bosses, the endless cubicle wars, died quietly at home in Pleasanton, California, on January 13, 2026. Scott Adams was 68. He had spent his final months in a public, unflinching fight against metastatic prostate cancer, a disease that had already spread to his bones when he first spoke of it openly in May 2025.

Over twenty-five years ago, I became a big fan of Scott Adams. I followed his work from the earliest Dilbert strips that captured the quiet madness of corporate life with such precision it felt almost personal. Long before his name became a lightning rod or his health a daily dispatch, I sent him an email. I never expected a reply. A man that busy, I thought, wouldn’t sift through the inbox clutter from strangers. To my quiet surprise, he answered with three plain words: “I read them.” A few more messages followed, brief and unpretentious. Back then he was still on pacbell (Pacific Bell), a telephone company in California which later merged and became a part of AT&T.

Through those exchanges, and through every strip he drew, every book he wrote, every stream he shared, Scott came across as genuinely kind and authentic, a man who worked hard to brighten days, even for people he would never meet, no matter how small their place in the world. What a wonderful bloke. As someone who spent decades inside the pharmaceutical industry, poring over his comics and books for sharp insight into corporate folly, I felt the sting of his diagnosis deeply.

Adams announced the diagnosis on his daily podcast, Real Coffee with Scott Adams. He compared his situation to that of former President Joe Biden, who had revealed a similar advanced prostate cancer around the same time. Adams was blunt: the cancer was terminal. Doctors gave him months. “Every day is a nightmare,” he said. He expected to leave this world by summer.

In the beginning, he turned to an alternative path pushed by Dr. William Makis, a physician known for promoting ivermectin and fenbendazole. Adams followed the protocol for about a month. It failed. The tumors kept growing. Later, he would call such claims about these drugs lacking solid evidence for prostate cancer.

After that disappointment, Adams started a common hormone therapy: pills that block testosterone, the fuel prostate cancer cells crave. Almost overnight, the bone-deep pain vanished. His PSA levels, a blood marker for prostate activity, dropped sharply, by 90%. For the first time in months, hope flickered. He told followers his odds of more time had jumped from near zero to perhaps 30%. He spoke of years, not weeks.

But the cancer was relentless. By late 2025, it pressed on his spine, leaving him paralyzed from the waist down. He needed a walker, then hospice care. Desperate for one more option, Adams appealed directly to President Donald Trump on X. He had been approved for Pluvicto, a targeted radiation drug for advanced prostate cancer, but his insurer, Kaiser Permanente in Northern California, delayed scheduling the infusion. “I am declining fast,” he wrote. Trump reposted the plea, promising action. Robert F. Kennedy Jr. and others stepped in. The appointment came quickly.

Around the same time, Adams received Anktiva, an immune-boosting drug sometimes called part of a “Bioshield” approach by its developer, Dr. Patrick Soon-Shiong. The idea was to protect the body’s cancer-fighting cells during radiation. It felt like a breakthrough moment, White House intervention, cutting-edge therapy, a final swing.

It wasn’t enough. The disease advanced. In early January 2026, Adams told his audience the odds of recovery were “essentially zero.” He entered hospice.

On New Year’s Day, he wrote a farewell note, calm and clear-headed.

A Final Message From Scott Adams

If you are reading this, things did not go well for me.

I have a few things to say before I go.

My body failed before my brain. I am of sound mind as I write this, January 1st, 2026. If you wonder about any of my choices for my estate, or anything else, please know I am free of any coercion or inappropriate influence of any sort. I promise.

Next, many of my Christian friends have asked me to find Jesus before I go. I’m not a believer, but I have to admit the risk-reward calculation for doing so looks attractive. So, here I go:

I accept Jesus Christ as my lord and savior, and I look forward to spending an eternity with him.The part about me not being a believer should be quickly resolved if I wake up in heaven. I won’t need any more convincing than that. And I hope I am still qualified for entry.

With your permission, I’d like to explain something about my life.

For the first part of my life, I was focused on making myself a worthy husband and parent, as a way to find meaning. That worked. But marriages don’t always last forever, and mine eventually ended, in a highly amicable way. I’m grateful for those years and for the people I came to call my family.

Once the marriage unwound, I needed a new focus. A new meaning. And so I donated myself to “the world,” literally speaking the words out loud in my otherwise silent home. From that point on, I looked for ways I could add the most to people’s lives, one way or another.

That marked the start of my evolution from Dilbert cartoonist to an author of—what I hoped would be—useful books. By then, I believed I had amassed enough life lessons that I could start passing them on. I continued making Dilbert comics, of course.

As luck would have it, I’m a good writer. My first book in the “useful” genre was How to Fail at Almost Everything and Still Win Big. That book turned out to be a huge success, often imitated, and influencing a wide variety of people. I still hear every day how much that book changed lives. My plan to be useful was working.

I followed up with my book Win Bigly, that trained an army of citizens how to be more persuasive, which they correctly saw as a minor super power. I know that book changed lives because I hear it often.

You’ll probably never know the impact the book had on the world, but I know, and it pleases me while giving me a sense of meaning that is impossible to describe.

My next book, Loserthink, tried to teach people how to think better, especially if they were displaying their thinking on social media. That one didn’t put much of a dent in the universe, but I tried.

Finally, my book Reframe Your Brain taught readers how to program their own thoughts to make their personal and professional lives better. I was surprised and delighted at how much positive impact that book is having.

I also started podcasting a live show called Coffee With Scott Adams, dedicated to helping people think about the world, and their lives, in a more productive way. I didn’t plan it this way, but it ended up helping lots of lonely people find a community that made them feel less lonely.

Again, that had great meaning for me.

I had an amazing life. I gave it everything I had. If you got any benefits from my work, I’m asking you to pay it forward as best you can. That is the legacy I want.

Be useful.

And please know I loved you all to the end.Scott Adams

His ex-wife, Shelly Miles, shared the news of his death during a livestream on his channel. The man who once drew Dilbert’s quiet rebellion against corporate nonsense left the world after a very public, very human struggle.

Prostate cancer begins in the small walnut-sized gland below a man’s bladder that helps make semen. In most cases, it grows slowly. Many men live with it for years without knowing. Doctors spot it early through blood tests for PSA or physical exams. Caught soon, surgery or radiation often cures it.

When it spreads, metastatic, as in Adams’s case, it heads to bones, causing severe pain, fractures, and weakness. Treatment then focuses on slowing it, easing suffering, and buying time. Hormone therapy is the cornerstone for many.

I don’t want to talk too deeply about COVID vaccination after Scott’s death, but I know many of you are as curious as I am, so let me share a little bit about the drug he probably took for prostate cancer. We all know he took COVID vaccines, he spoke at length about it and made a “semi” U-Turn in 2023 (before his cancer diagnosis) which you can see below.

Scott Adams' U-Turn on COVID Vaccines

Let’s examine Leuprolide Drug Sales.

Leuprolide is one of the most widely used drugs for prostate cancer and I suspect it is what Scott Adams took. It’s a shot given every month or few months. In simple terms, prostate cancer cells act like addicts to testosterone, the main male hormone. Feed them testosterone, and they grow faster. Lupron (the Brand name for Leuprolide) tricks the body into shutting down testosterone production in the testicles. The cancer starves, tumors often shrink, pain lessens, and progression slows.

It is an old drug, first approved in the 1980s and rooted in discoveries from the 1970s. Decades on the market have made its benefits and limits well known to doctors and patients alike; year after year, prices creep up only in small increments, a predictable drift rather than the sharp jumps seen with newer medicines.

As I explained in my previous articles, I use Singapore drug sales data as an analog to track disease trends because of its “clean” nature. Its tiny, tightly controlled market leaves little room for generics to enter, delivering undistorted sales data that reveal real usage shifts over time. There is no generic leuprolide on the market. What you see is what patients are actually getting. It is also the country that used the earliest, and probably the most DNA/SV40 contaminated batches of Pfizer COVID vaccines, which is now suspected to cause hyper-progressive cancer.

And the majority of the Singaporean population has taken at least three doses of Pfizer COVID Vaccines because of extreme government coercion. Singapore’s Health Minister Mr Ong Ye Kung, in August 2021 boasted that Singapore ‘might well be the most vaccinated country in the world’.

If you want a deeper explanation, head to the article below where I wrote about the staggering increases in ALS drug use post-vaccination in Singapore.

Here is the sales of Lupron (in doses) for Singapore from 2015-2025. If you simply eyeball it, you can see steady small increases in pre-covid years from 2015 to 2019 and after the population was subjected to the experimental therapy, the drug usage became more volatile.

I dumped the raw data into Grok for analysis and here is the conclusion. It says 2021 is the key inflection point for acceleration. One has to wonder what happened in 2021.

There is clear acceleration in the upward trend after 2020 (starting in 2021), as evidenced by higher YoY growth rates (from ~6% in 2020 to 13–18% afterward) and a more than doubled linear slope (from ~206 pre-2020 to ~502 post-2020). The trend does not accelerate markedly further after 2021 (post-2021 slope is only ~9% higher than post-2020), though growth rates do climb progressively into 2024.

Between 2020 and 2021, the more profound shift occurs in 2021: 2020 represents a deceleration (growth halving from prior years), while 2021 marks the rebound and initiation of sustained higher growth. This makes 2021 the key inflection point for acceleration.

Anyway, Scott Adams tried everything he could, alternative protocols first, then the standard hormone blockade that briefly lifted the fog of pain, then the experimental infusions delivered only after presidential intervention. None of it held back the tide. In the end, metastatic prostate cancer proved as merciless.

For the laughter he gave us when the world felt heaviest, we owe him a quiet, lasting thanks.

Rest well, Scott.

Signing off for now
A17